E
Marvel Biosciences Corp. MRVL.V
TSX
Recommendation
Prev Close
$0.10
Volume
--
Avg Vol (90D)
34,179
Market Cap
$3.24M
Dividend & Yield
--
52-Week Range
$0.06 - $0.18
P/E (TTM)
--
EPS (TTM)
-$0.0286
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
MarketBeat Week in Review – 04/14 - 04/18
4/19/2025 - MarketBeat
6,125 Shares in Marvell Technology, Inc. (NASDAQ:MRVL) Acquired by Kovitz Investment Group Partners LLC
5/1/2025 - MarketBeat
Marvell Technology (MRVL) Stock Sinks As Market Gains: What You Should Know
4/30/2025 - Zacks Investment Research
Marvell Technology (NASDAQ:MRVL) Trading Up 0% - Here's Why
4/30/2025 - MarketBeat
These 2 Nasdaq-100 Stocks Are Down Around 50% This Year
4/30/2025 - Fool.com Headlines
Schonfeld Strategic Advisors LLC Grows Stake in Marvell Technology, Inc. (NASDAQ:MRVL)
4/30/2025 - MarketBeat
Northern Trust Corp Purchases 1,287,557 Shares of Marvell Technology, Inc. (NASDAQ:MRVL)
4/30/2025 - MarketBeat
The Manufacturers Life Insurance Company Has $149.44 Million Holdings in Marvell Technology, Inc. (NASDAQ:MRVL)
4/30/2025 - MarketBeat
Why Marvell Technology, Inc. (MRVL) is Among the Best Oversold NASDAQ Stocks to Buy Right Now
4/30/2025 - Insider Monkey
Astera Labs vs. Marvell: Which AI Infrastructure Stock is a Better Buy?
4/29/2025 - Zacks Investment Research
Marvell Technology (NASDAQ:MRVL) Trading Down 1.5% - What's Next?
4/29/2025 - MarketBeat
11 Oversold NASDAQ Stocks to Buy Right Now
4/29/2025 - Insider Monkey
Marvell Technology, Inc. (NASDAQ:MRVL) Shares Sold by California State Teachers Retirement System
4/29/2025 - MarketBeat
Bellwether Advisors LLC Invests $4.35 Million in Marvell Technology, Inc. (NASDAQ:MRVL)
4/29/2025 - MarketBeat
Marvell Technology (MRVL) Stock Sinks As Market Gains: Here's Why
4/28/2025 - Zacks Investment Research
Is Lam Research Stock a Buy Post Upbeat Q3 Earnings Performance?
4/28/2025 - Zacks Investment Research
Marvell Technology (NASDAQ:MRVL) Shares Down 1.5% - What's Next?
4/28/2025 - Zolmax
Marvell Technology, Inc. (NASDAQ:MRVL) Shares Sold by Public Employees Retirement Association of Colorado
4/28/2025 - MarketBeat
5 Stocks With Lucrative Valuation and Price Upside to Buy on the Dip
4/28/2025 - Zacks Investment Research
Boothbay Fund Management LLC Lowers Position in Marvell Technology, Inc. (NASDAQ:MRVL)
4/28/2025 - MarketBeat
14,738 Shares in Marvell Technology, Inc. (NASDAQ:MRVL) Purchased by Gilder Gagnon Howe & Co. LLC
4/28/2025 - MarketBeat
Marvell Technology (MRVL) Achieves Record Data Center Revenue Growth
4/27/2025 - GuruFocus
Aquatic Capital Management LLC Makes New $24.75 Million Investment in Marvell Technology, Inc. (NASDAQ:MRVL)
4/27/2025 - MarketBeat
Adage Capital Partners GP L.L.C. Sells 274,500 Shares of Marvell Technology, Inc. (NASDAQ:MRVL)
4/27/2025 - MarketBeat
Marvell Gets Tariff Lifeline But Expect More Volatility
4/11/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
-$945.00K
Net Income (TTM)
-$1.20M
Balance Sheet
Total Assets (Q)
$151.40K
Total Debt (Q)
$1.18M
Total Liabilities (Q)
$2.60M
Book Value Per Share (Q)
-$0.0547
Cash Flow
Cash from Operations (TTM)
-$724.80K
Cash from Investing (TTM)
--
Cash from Financing (TTM)
$344.00K
Net Change in Cash (TTM)
-$380.70K
Filings
Filing Date
Monday, March 31, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Jun 16 and 20 (est)
Price History
Loading...
Beta
0.12
7-Day Total Return
0.00%
30-Day Total Return
-28.57%
60-Day Total Return
-35.48%
90-Day Total Return
-37.50%
Year to Date Total Return
-33.33%
1-Year Total Return
-35.48%
2-Year Total Return
11.11%
3-Year Total Return
-25.93%
5-Year Total Return
--
52-week Low
May 17, 2024 - $0.06
52-week High
Nov 15, 2024 - $0.18
Valuation
Market Cap
$3.24M - Nano Cap
Enterprise Value
$4.43M
Price/Sales (TTM)
--
Price/Book (Q)
-1.83
Dividends and Shares
Shares Outstanding
44.79M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
marvelbiotechnology.com
Phone Number
403 770 2469
Address
505 8th Avenue S.W.
Calgary, AB T2P 1G2
Country
Canada
Year Founded
--
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada. The company’s lead compound... more